M. Schlichting
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
-
- Vitamin D Research Studies
- Genetic factors in colorectal cancer
Papers in
- Oncology 16
- Colorectal Cancer Treatments and Studies 10
- Polyomavirus and related diseases 4
- Cancer Treatment and Pharmacology 3
-
- Lung Cancer Treatments and Mutations 7
- Co-authors
- Carsten Bokemeyer (7 shared papers)İ. Çelik (3 shared papers)Filippo de Braud (1 shared paper)Gunter Schuch (1 shared paper)P. Koralewski (1 shared paper)J.T. Hartmann (1 shared paper)Angela Zubel (1 shared paper)Igor Bondarenko (1 shared paper)
- Journals
- Annals of Oncology (10 papers)Journal of Clinical Oncology (6 papers)Value in Health (2 papers)Dermatology (1 paper)Osteoporosis International (1 paper)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
M. Schlichting
20 papers receiving 1.3k citations
M. Schlichting's Hit Papers
Peers
Comparison fields: 5 of 76
- Oncology 742
- Pathology and Forensic Medicine 453
- Orthopedics and Sports Medicine 199
- Hepatology 152
- Pulmonary and Respiratory Medicine 232
Countries citing papers authored by M. Schlichting
This map shows the geographic impact of M. Schlichting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Schlichting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Schlichting more than expected).
Fields of papers citing papers by M. Schlichting
This network shows the impact of papers produced by M. Schlichting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Schlichting. The network helps show where M. Schlichting may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Schlichting, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study Hit paper breakdown → | 2011 | 613 |
| 2 | 2002 | 411 | |
| 3 | 2010 | 64 | |
| 4 | 2009 | 63 | |
| 5 | 2009 | 38 | |
| 6 | 2011 | 37 | |
| 7 | 2016 | 18 | |
| 8 | 2011 | 11 | |
| 9 | The crystal study: Assessment of the predictive value of KRAS status on clinical outcome in patients with mcrc receiving first-line treatment with cetuximab or cetuximab plus folfiri | 2008 | 11 |
| 10 | 2011 | 8 | |
| 11 | 2005 | 6 | |
| 12 | 2003 | 5 | |
| 13 | 2017 | 5 | |
| 14 | 2023 | 1 | |
| 15 | The blood picture of 200 Thoroughbreds. | 1956 | 1 |
| 16 | 2011 | 1 | |
| 17 | 2019 | 1 | |
| 18 | 2018 | 1 | |
| 19 | 2012 | 1 | |
| 20 | 2023 | 1 |
About M. Schlichting
M. Schlichting is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Surgery and Ecology, having authored 22 papers that have together received 1.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (10 papers), Lung Cancer Treatments and Mutations (7 papers), Radiomics and Machine Learning in Medical Imaging (4 papers), Polyomavirus and related diseases (4 papers), Cancer Treatment and Pharmacology (3 papers), Plant Virus Research Studies (3 papers), Bacteriophages and microbial interactions (3 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). The work is most often cited by research in Oncology (742 citations), Pathology and Forensic Medicine (453 citations), Orthopedics and Sports Medicine (199 citations), Hepatology (152 citations) and Pulmonary and Respiratory Medicine (232 citations). M. Schlichting has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Carsten Bokemeyer, İ. Çelik, Filippo de Braud, Gunter Schuch, P. Koralewski, J.T. Hartmann, Angela Zubel, Igor Bondarenko, Raymond Pamphile and M. C. Chapuy. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Value in Health, Dermatology and Osteoporosis International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.